News ArticleFortis Healthcare Q2 FY27 Revenue Climbs 17.3% to INR 2,735 Cr with Strategic Hospital Expansions
Hospital business revenue rises 18.6% with 12.1% PAT margin; diagnostics revenue up 12.2%, net debt improves to INR 2,188 crore
Fortis Healthcare announced its Q2 FY27 consolidated financial results, reporting a 17.3% year-on-year increase in revenues to INR 2,735 crore. The hospital business revenue rose 18.6%, while the diagnostics business recorded a 12.2% revenue increase. Profit after tax margin declined overall to 11.7% from 14.1% in Q2 FY26, with hospital PAT margin at 12.1% and diagnostics at 15.2%. Net debt stood at INR 2,188 crore, with a Net Debt to EBITDA ratio of 0.87x. Strategic expansions include acquiring Suguna Hospital in Bengaluru and a healthcare services agreement for a 400+ bed hospital in New Del
Fortis Healthcare Limited
General / Other
Fortis Healthcare announced its unaudited consolidated financial results for the quarter ended September 30, 2026, reporting consolidated revenues of INR 2,735 crore, a 17.3% increase year-on-year. The company saw revenue growth in both its hospital and diagnostics businesses while profit after tax margin narrowed.
Consolidated revenues reached INR 2,735 crore in Q2 FY27, up 17.3% from INR 2,331 crore a year earlier. Profit before tax (excluding exceptional items) increased 6.8% to INR 429 crore. Profit after tax declined 2.5% to INR 320 crore with a margin of 11.7% compared to 14.1% in Q2 FY26.
The hospital segment recorded revenue of INR 2,340 crore, growing 18.6%, while PAT margin declined from 14.5% to 12.1%. The diagnostics business saw a 12.2% increase in gross revenues to INR 448 crore and improved PAT margin of 15.2%.
Fortis’s net debt as of September 30, 2026 stood at INR 2,188 crore, with a Net Debt to EBITDA ratio of 0.87x and net debt to equity at 0.20x, both improved from the previous year.
Key hospital business highlights include a 7% rise in average revenue per patient and a 9% increase in occupied beds compared to Q2 FY26. Fortis acquired the 110-bed Suguna Hospital in Bengaluru and entered a long-term healthcare services contract for a 400+ bed super-specialty hospital in Ashok Vihar, New Delhi, expected to start operations in 3 to 4 years.
The diagnostics business expanded its network to 4,551 customer touch points and conducted approximately 11.39 million tests in Q2 FY27, with preventive and specialized portfolios growing significantly.
Highlights
- Consolidated Q2 FY27 revenue at INR 2,735 crore, up 17.3% year-on-year
- Hospital business revenue up 18.6% to INR 2,340 crore, PAT margin at 12.1%
- Diagnostics business gross revenue rose 12.2% to INR 448 crore, PAT margin increased to 15.2%
- Net debt reduced to INR 2,188 crore with improved debt ratios
- Acquisition of 110-bed Suguna Hospital in Bengaluru completed
- Entered healthcare services agreement for 400+ bed super-specialty hospital in Ashok Vihar, New Delhi, to commence in 3–4 years
Key Data Snapshot
What happened
- Fortis Healthcare reported consolidated revenue of INR 2,735 crore for Q2 FY27, increasing by 17.3% year-on-year.
- Profit after tax margin contracted to 11.7% in Q2 FY27 compared to 14.1% in Q2 FY26.
- Hospital business revenues rose to INR 2,340 crore, up 18.6%, with PAT margin falling to 12.1%.
- Diagnostics business gross revenue grew 12.2% to INR 448 crore, with PAT margin up slightly to 15.2%.
- Net debt as of September 30, 2026, stood at INR 2,188 crore, improving net debt to EBITDA and equity ratios.
Key details
- Hospital business saw a 7% increase in average revenue per inpatient patient (ARPP) and a 9% increase in occupancy compared to the prior year quarter.
- Fortis acquired Suguna Hospital, a 110-bed facility in Bengaluru, which can potentially expand to 150 beds.
- A long-term agreement was signed to provide healthcare services to a 400+ bed super-specialty hospital in Ashok Vihar, New Delhi, expected to start operations in 3-4 years subject to approvals.
- Diagnostics business expanded to 4,551 customer touch points and conducted approximately 11.39 million tests during the quarter.
- Preventive and specialized diagnostic services revenues grew by 28% and 14%, respectively, year-on-year for Q2 FY27.
Strategic context
- The company plans to continue its inorganic growth strategy by evaluating further acquisitions and greenfield opportunities in major Indian markets such as Mumbai, Kolkata, and Hyderabad.
- Expansion plans also include select Tier 2 markets to broaden geographic presence.
- These initiatives aim to strengthen Fortis’ competitive position and deliver network synergies in key clusters.
- The diagnostics business focuses on capacity expansion and increasing consumer touchpoints to capitalize on growing healthcare demand in India.
Highlights
- Consolidated Q2 FY27 revenue at INR 2,735 crore, up 17.3% year-on-year
- Hospital business revenue up 18.6% to INR 2,340 crore, PAT margin at 12.1%
- Diagnostics business gross revenue rose 12.2% to INR 448 crore, PAT margin increased to 15.2%
- Net debt reduced to INR 2,188 crore with improved debt ratios
- Acquisition of 110-bed Suguna Hospital in Bengaluru completed
- Entered healthcare services agreement for 400+ bed super-specialty hospital in Ashok Vihar, New Delhi, to commence in 3–4 years
Disclosures
- SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
Source Information
More News on General / Other
View allLatest corporate announcements and market updates in General / Other.
Sansera Engineering Achieves Record INR 10,915 Million Quarterly Revenue and 59% Normalised PAT Growth in Q2 FY27
Sansera Engineering Limited reported its highest-ever quarterly revenue of INR 10,915 million for Q2 FY27, a 32% increase year-over-year, alongside a normalized profit after tax of INR 1,000 million, up 59% YoY excluding an exceptional litigation-related cost.
Read Full Story
Godfrey Phillips India Declares ₹10 Interim Dividend and Posts ₹16,298 Lakh Profit for Q2 FY2027
Godfrey Phillips India Limited declared an interim dividend of 500% or ₹10 per equity share for the financial year ending March 31, 2027, while reporting an unaudited standalone net profit of ₹16,298 lakh for the quarter ended September 30, 2026.
Read Full Story
IKS Health Doubles Revenue with 103.9% YoY Growth and Boosts EBITDA by 62.5% in Q2 FY27 Post TruBridge Deal
Inventurus Knowledge Solutions Limited (IKS Health) announced strong Q2 FY27 financial results with revenue surpassing INR 15,900 million, marking a 103.9% year-on-year increase supported by its TruBridge acquisition and sustained organic growth.
Read Full Story
